Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renoral vs. Aminoven in End-Stage Renal Disease
NCT03807583Unknown
- Sponsor
- INDIGO Biosciences
- Start
- Mar 2019
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Randomised, open-label trial of Renoral in end stage renal disease (ESRD) (3 arms), sponsored by INDIGO Biosciences. Primary endpoint: Plasma total amino acid concentration. Status: unknown.
02
Drugs
Renoral
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03807583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03807583.